Who Owns Tyra Biosciences Stock?
NASDAQ: TYRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 115.79%
- Institutions (% of float)
- 118.66%
- Held by insiders
- 2.42%
- Institutional holders
- 225
- Institutions 97.6%
- Insiders 2.4%
- Public and other 0.0%
Who owns Tyra Biosciences stock?
Institutional investors own about 115.8% of Tyra Biosciences's shares, spread across 225 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.42% of TYRA.
The largest institutional holders are RA Capital Management, L.P. (17.66%), FMR, LLC (15.25%) and Janus Henderson Group Ltd. (7.62%). Together, the top 10 institutions control 77.0% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TYRA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TYRA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 12.20M | 17.66% | 0.0% |
| FMR, LLC | 10.54M | 15.25% | +18.1% |
| Janus Henderson Group Ltd. | 5.26M | 7.62% | +35.2% |
| BVF Inc. | 4.22M | 6.10% | +185.6% |
| Alta Partners Management Company, L.P. | 3.82M | 5.53% | 0.0% |
| Paradigm Biocapital Advisors LP | 3.51M | 5.08% | +92.0% |
| TCG Crossover Management, LLC | 3.48M | 5.03% | +7.0% |
| Nextech Invest, Ltd. | 3.45M | 4.99% | -3.0% |
| Siren, L.L.C. | 3.40M | 4.92% | +368.4% |
| Blackrock Inc. | 3.36M | 4.86% | +10.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TYRA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Securities Fund-Fidelity OTC Portfolio | 3.32M | 4.80% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.15M | 1.67% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.14M | 1.64% |
| iShares Trust-iShares Russell 2000 ETF | 956.77K | 1.38% |
| T. Rowe Price New Horizons Fund, Inc. | 793.14K | 1.15% |
| Fidelity Advisor Series I-Fidelity Advisor Equity Growth Fund | 678.60K | 0.98% |
| Variable Insurance Products Fund-Growth Portfolio | 630.80K | 0.91% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 558.50K | 0.81% |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 529.56K | 0.77% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 519.99K | 0.75% |
Frequently asked questions
Who is the largest shareholder of Tyra Biosciences?
RA Capital Management, L.P. is the largest institutional shareholder of TYRA, owning 17.66% of shares outstanding (12.20M shares) as of its latest 13F filing.
What percentage of Tyra Biosciences is owned by institutions?
Institutions own about 115.8% of TYRA shares and 118.7% of the public float.
How much of Tyra Biosciences do insiders own?
Insiders, such as officers and directors, own about 2.42% of TYRA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.